UltraTech Cement shares gain on India Cements acquisition; Check deal contours, industry impact, stock price outlook

  • Aditya Birla Group-owned UltraTech Cement said its board of directors approved the acquisition of a 32.72% equity stake of the promoters and their associates in India Cements for 3,954 crore at 390 per share.

Ankit Gohel
Published29 Jul 2024, 09:29 AM IST
Trade Now
UltraTech Cement shares gain on India Cements acquisition; Check deal contours, industry impact, stock price outlook
UltraTech Cement shares gain on India Cements acquisition; Check deal contours, industry impact, stock price outlook(Photo: Reuters)

UltraTech Cement share price gained over a percent in early trade on Monday after the company announced the acquisition of another 32.72% stake in India Cements. Meanwhile, India Cements share price also rallied nearly 3% on BSE.

The Aditya Birla Group-owned UltraTech Cement said its board of directors approved the acquisition of a 32.72% equity stake of the promoters and their associates in India Cements for 3,954 crore at 390 per share. The price is 4.1% higher than India Cements share’s closing price of 374.60 apiece last Friday.

In June 2024, UltraTech had made a financial investment in south India-based cement manufacturer India Cements to acquire 22.77% equity at a price of 268 per share. With the latest announcement, UltraTech Cement will become the majority shareholder in India Cements with a holding of 55.49% stake.

Also Read | UltraTech Cement board approves 32.72% acquisition of India Cements

The stake sale will also trigger a mandatory open offer. Both the stake sale and open offer will be subject to regulatory approvals, UltraTech Cement said in a stock exchange filing.

Analysts believe the acquisition will significantly strengthen UltraTech’s position, and expect the company’s capacity market share to more than double in the Southern region.

Here’s how the UltraTech Cement - India Cements deal will impact the Aditya Birla Group company.

Deal Valuation

Assuming 70% - 75% utilization with EBITDA per tonne of 1,000 - 1,200 in FY26E and FY27E, the implied valuation stands at 13.5x/10.5x EV/E, 30-35% discount to what UltraTech is currently trading at, according to Dharmesh Shah, Research Analyst at Emkay Global Financial Services.

These assets are likely to generate EBITDA of 1,000 - 1,300 crore in FY26/FY27E, which would be around 5-6% of our current estimates (currently not factored into our estimates), he said.

Also Read | N. Srinivasan sells his stake in ICL to UltraTech, cements his gritty legacy

Capacity

India Cements has a total capacity of 14.45 mtpa of grey cement. Of this, 12.95 mtpa is in the South (particularly Tamil Nadu) and 1.5 mtpa is in Rajasthan.

The acquisition of India Cements will add 9% to UltraTech Cement’s current capacity and augments its capacity share by 2% on a pan-India basis. Post the acquisition, UltraTech’s cement capacity would increase to 214 MT, including Kesoram, by FY27E from the current 156 MT ex-Kesoram.

UltraTech Cement’s capacity share in the South is expected to almost double from the current ~13% to more than 25% by FY25 as its capacities there are expected to increase to over 50 MT from the current 25 MT.

Also Read | In the grinding battle for cement, UltraTech makes a big move in the south

Industry Impact

The increased consolidation in the cement industry is expected to benefit the top two groups in terms of market share. According to Antique Stock Broking, the top 2 groups - UltraTech Cement and Adani Group are expected to account for half of the cement industry volume by FY27-28.

UltraTech Cement is estimated to account for ~1/3rd of the industry volume by FY27E aided by a few M&As. Emkay Global estimates that UltraTech capacity market share would increase from 11% in FY24 to 25% by FY27E, in line with its capacity market share of >20% in other regions.

Analysts believe industry consolidation will be positive for price discipline and price improvement, and can generate significantly better profitability and return ratios in the longer term.

Also Read | Stock market today: Five stocks to buy or sell on Monday — July 29

However, in the near term, industry profitability could remain capped as companies may look to improve utilization given acquired assets are operating at low utilization levels. Analysts expect this scenario (ramp up of assets, consolidation) to continue for another 4-6 quarters at least.

UltraTech Cement share price outlook

Emkay Global maintained a ‘Buy’ rating on UltraTech Cement shares with June 2025 target price of 12,800 per share.

Antique Stock Broking also maintained a ‘Buy’ call with an unchanged UltraTech Cement share price target of 12,400 apiece. UltraTech Cement remains the brokerage firm’s top pick.

At 9:25 AM, UltraTech Cement shares were trading 1.21% higher at 11,820.65, while India Cements shares were trading 0.56% higher at 376.70 apiece on the BSE.

Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:29 Jul 2024, 09:29 AM IST
Business NewsMarketsStock MarketsUltraTech Cement shares gain on India Cements acquisition; Check deal contours, industry impact, stock price outlook

Most Active Stocks

Tata Steel share price

163.90
02:07 PM | 7 OCT 2024
-2.85 (-1.71%)

Axis Bank share price

1,144.95
02:07 PM | 7 OCT 2024
-32.55 (-2.76%)

Bharat Electronics share price

267.20
02:07 PM | 7 OCT 2024
-10 (-3.61%)

Tata Power share price

442.45
02:07 PM | 7 OCT 2024
-24.25 (-5.2%)
More Active Stocks

Market Snapshot

  • Top Gainers
  • Top Losers
  • 52 Week High

Eclerx Services share price

3,119.65
02:04 PM | 7 OCT 2024
96.6 (3.2%)

Coforge share price

7,236.95
02:03 PM | 7 OCT 2024
113.8 (1.6%)

Vijaya Diagnostic Centre share price

988.75
02:04 PM | 7 OCT 2024
-0.2 (-0.02%)

Dr. Lal Pathlabs share price

3,465.00
02:02 PM | 7 OCT 2024
-29.25 (-0.84%)
More from 52 Week High

Bombay Burmah Trading Corporation share price

2,505.05
02:04 PM | 7 OCT 2024
-260.2 (-9.41%)

Rail Vikas Nigam share price

455.15
02:05 PM | 7 OCT 2024
-37.95 (-7.7%)

Railtel Corporation Of India share price

398.75
02:04 PM | 7 OCT 2024
-32.8 (-7.6%)

VIP Industries share price

521.70
02:04 PM | 7 OCT 2024
-42.15 (-7.48%)
More from Top Losers

Finolex Industries share price

287.45
02:05 PM | 7 OCT 2024
15.8 (5.82%)

CG Power & Industrial Solutions share price

750.25
02:05 PM | 7 OCT 2024
31.45 (4.38%)

Astrazeneca Pharma India share price

7,757.00
02:04 PM | 7 OCT 2024
324.5 (4.37%)

Natco Pharma share price

1,399.00
02:05 PM | 7 OCT 2024
44.35 (3.27%)
More from Top Gainers

Recommended For You

    More Recommendations

    Gold Prices

    • 24K
    • 22K
    Bangalore
    77,675.00-10.00
    Chennai
    77,681.00-10.00
    Delhi
    77,833.00-10.00
    Kolkata
    77,685.00-10.00

    Fuel Price

    • Petrol
    • Diesel
    Bangalore
    102.86/L0.00
    Chennai
    100.75/L0.00
    Kolkata
    104.95/L0.00
    New Delhi
    94.72/L0.00

    Popular in Markets

      HomeMarketsPremiumInstant LoanMint Shorts